DaVita Inc Stock Surges 25% Post Q4 Beat, Raises 2026 Outlook: DVA

[Para 1: The Lead] DaVita Inc (DVA) stock soared 25% in after-hours trading following the company's Q4 earnings release and outlook revision. The healthcare provider exceeded Wall Street estimates, with earnings per share of $2.15, up from $1.85 in the same period last year. Revenue came in at $4.1 billion, surpassing analyst forecasts of $3.95 billion. [Para 2-3: Supporting details & Context] DaVita raised its 2026 revenue guidance to $17.5 billion from $16.5 billion, reflecting strong patient demand and cost management strategies. The company also announced a $0.10 per share dividend increase, effective in the second quarter. Analysts attribute the positive performance to improved patient volume and cost efficiency. DVA's market capitalization has now surpassed $20 billion.